With a Foreword by Richard D. Klausner, M.D., Director, National Cancer Institute and an Introduction by Henry T. Lynch, M.D., President, Hereditary Cancer Institute and Director, Creighton Cancer Center, Creighton University
When ordering a genetic test to determine whether a patient is susceptible to genetically transmitted cancers, physicians must be prepared to cope with profound medical, psychological, and ethical consequences. They, along with genetic counselors, nurses, psychologists, and other health professionals, must ensure that interpretations of test results are accurate, risk assessments are appropriate, and the communication of risk information is clear, helpful, and productive.
Clinical Cancer Genetics: Risk Counseling and Management is a comprehensive practical guide for health professionals responding to the growing demand for clinical cancer genetic services. Using examples drawn from actual cases and emphasizing fundamental principles throughout, this book outlines the scope of clinical cancer genetics and its underlying scientific concepts, reviews the most prevalent syndromes of cancer predisposition, and addresses major issues associated with genetic testing, including:
Supplemented with practical materials used in cancer genetic counseling programs and an annotated table of selected human cancer predisposition syndromes, Clinical Cancer Genetics: Risk Counseling and Management equips health care professionals with a complete understanding of the benefits and limitations of genetic testing technologies and the ability to integrate genetic information into the management of patients who are at risk or already affected by cancer.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
KENNETH OFFIT is Chief of the Clinical Genetics Service in the Department of Human Genetics at Memorial Sloan-Kettering Cancer Center. He attended Princeton University and the Harvard Medical School and received an M.P.H. from the Harvard School of Public Health. Dr. Offit chaired the Subcommittee on Genetic Testing for Cancer Susceptibility of the American Society of Clinical Oncology, and is a member of the Cancer Genetics Working Group of the National Cancer Institute.
With a Foreword by Richard D. Klausner, M.D., Director, National Cancer Institute and an Introduction by Henry T. Lynch, M.D., President, Hereditary Cancer Institute and Director, Creighton Cancer Center, Creighton University.
When ordering a genetic test to determine whether a patient is susceptible to genetically transmitted cancers, physicians must be prepared to cope with profound medical, psychological, and ethical consequences. They, along with genetic counselors, nurses, psychologists, and other health professionals, must ensure that interpretations of test results are accurate, risk assessments are appropriate, and the communication of risk information is clear, helpful, and productive.
Clinical Cancer Genetics: Risk Counseling and Management is a comprehensive practical guide for health professionals responding to the growing demand for clinical cancer genetic services. Using examples drawn from actual cases and emphasizing fundamental principles throughout, this book outlines the scope of clinical cancer genetics and its underlying scientific concepts, reviews the most prevalent syndromes of cancer predisposition, and addresses major issues associated with genetic testing, including:
* Use of quantitative methods in risk counseling
* Methodologies of genetic testing
* Genetic testing of patients with cancer
* Reproductive risk counseling of cancer patients
* Special psychological, ethical, and legal challenges in clinical cancer genetics
Supplemented with practical materials used in cancer genetic counseling programs and an annotated table of selected human cancer predisposition syndromes, Clinical Cancer Genetics: Risk Counseling and Management equips health care professionals with a complete understanding of the benefits and limitations of genetic testing technologies and the ability to integrate genetic information into the management of patients who are at risk or already affected by cancer.
With a Foreword by Richard D. Klausner, M.D., Director, National Cancer Institute and an Introduction by Henry T. Lynch, M.D., President, Hereditary Cancer Institute and Director, Creighton Cancer Center, Creighton University.
When ordering a genetic test to determine whether a patient is susceptible to genetically transmitted cancers, physicians must be prepared to cope with profound medical, psychological, and ethical consequences. They, along with genetic counselors, nurses, psychologists, and other health professionals, must ensure that interpretations of test results are accurate, risk assessments are appropriate, and the communication of risk information is clear, helpful, and productive.
Clinical Cancer Genetics: Risk Counseling and Management is a comprehensive practical guide for health professionals responding to the growing demand for clinical cancer genetic services. Using examples drawn from actual cases and emphasizing fundamental principles throughout, this book outlines the scope of clinical cancer genetics and its underlying scientific concepts, reviews the most prevalent syndromes of cancer predisposition, and addresses major issues associated with genetic testing, including:
* Use of quantitative methods in risk counseling
* Methodologies of genetic testing
* Genetic testing of patients with cancer
* Reproductive risk counseling of cancer patients
* Special psychological, ethical, and legal challenges in clinical cancer genetics
Supplemented with practical materials used in cancer genetic counseling programs and an annotated table of selected human cancer predisposition syndromes, Clinical Cancer Genetics: Risk Counseling and Management equips health care professionals with a complete understanding of the benefits and limitations of genetic testing technologies and the ability to integrate genetic information into the management of patients who are at risk or already affected by cancer.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: ThriftBooks-Dallas, Dallas, TX, USA
Hardcover. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less. Artikel-Nr. G0471146552I4N00
Anzahl: 1 verfügbar
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Artikel-Nr. FW-9780471146551
Anzahl: 15 verfügbar
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In. Artikel-Nr. ria9780471146551_new
Anzahl: Mehr als 20 verfügbar
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. pp. 440. Artikel-Nr. 7355629
Anzahl: 3 verfügbar
Anbieter: moluna, Greven, Deutschland
Gebunden. Zustand: New. I refer to [this book] frequently and almost feel as if Dr. Offit was in the consulting room. I urge oncologists and other professionals providing cancer risk counseling to read this book and keep it at hand for convenient reference. --Annals of Oncology . Artikel-Nr. 446914725
Anzahl: Mehr als 20 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Hardcover. Zustand: Brand New. 1st edition. 440 pages. 9.75x6.75x1.00 inches. In Stock. Artikel-Nr. x-0471146552
Anzahl: 2 verfügbar
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. This comprehensive guide helps health care professionals use genetics in managing patients at risk for, or already diagnosed with, common cancers. It offers health care professionals a framework for counseling patients, families, and colleagues about the availability, benefits, and limitations of the new technologies for genetic risk assessment. Num Pages: 440 pages, Illustrations. BIC Classification: JKSN2; MFN; MJCL. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 244 x 163 x 30. Weight in Grams: 760. . 1998. Hardback. . . . . Books ship from the US and Ireland. Artikel-Nr. V9780471146551
Anzahl: Mehr als 20 verfügbar
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Neuware - Ein wichtiger und umfassender Leitfaden für Präventivmediziner, die sich mit der genetischen Analyse von Krebspatienten oder potentiellen Risikopatienten für häufige Krebsarten beschäftigen. Es werden entscheidende Konzepte aus den Bereichen der Epidemiologie und Sozialwissenschaften eingeführt, um so einen integrierten Ansatz für jeden individuellen Fall zu ermöglichen. Dieses Werk ist von unschätzbarem Wert für die Beratung von Patienten, Familien und Kollegen hinsichtlich Verfügbarkeit, Nutzen und Grenzen der neuen Technik der genetischen Risikoanalyse. Ferner werden kommerzielle DNA Tests zur Bestimmung der familiär bedingten Veranlagung für mögliche Krebserkrankungen sowie deren soziale und ethische Aspekte näher betrachtet. (12/97). Artikel-Nr. 9780471146551
Anzahl: 2 verfügbar